possible increased risk of cleft lip and palate in babies exposed to Lamictal during pregnancy

The FDA is warning about a possible increased risk of cleft lip and palate in babies exposed to Lamictal during pregnancy.

This is due to a recent report from the North American Antiepileptic Drug (NAAED) Pregnancy Registry.

But the risk seems low...an increase from 0.05% to 0.3% in general to 0.9% in babies exposed to Lamictal (lamotrigine).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote